Jubilant Ingrevia In Focus: Anand Rathi Bets On Earnings Inflection - Buy, Sell or Hold?

FY27 is shaping up as an inflection year for Jubilant Ingrevia, with contract development manufacturing organisation ramp-up, improving nutrition mix and operating leverage across newly commissioned...